Homozygous familial hypercholesterolemia (FH) is an inherited disease characterized by massive elevations in serum cholesterol, premature and accelerated atherosclerosis, and early cardiac death. FH arises from alleles encoding defective low density lipoprotein (LDL) receptors. Liver-directed gene therapy is being used to effect a metabolic cure by reconstituting hepatic expression of normal LDL receptors. Clinical trials of ex vivo gene therapy for FH are currently underway at our institution, under the auspices of Dr. James Wilson and the Institute for Human Gene Therapy (IHGT). The Radiology Department and IHGT have formed a collaboration to develop methods for the noninvasive detection of transgene products in vivo. In particular, we are working to develop MR contrast agents (and, more recently, radiopharmaceuticals) targeted to the human LDL receptor transgene product. Our first strategy was to prepare LDL particles reconstituted with hydrophobic superparamagnetic iron oxide (SPIO) nanoparticles. Twenty different types of reconstituted LDL particles were prepared using a variety of apolar solvents, SPIO surfactants, and apoprotein-B100 (apo-B) stabilizing agents. We are now pursuing a different strategy for preparing these contrast agents. Surfactant-stabilized hydrophilic SPIO particles or multimeric gadolinium chelates will be covalently attached to apo-B or to the sugar moiety on apo-B. Preliminary studies will explore the specific kinds of covalent modification to apo-B that result in retention of receptor binding activity. LDL receptor-targeted contrast agents that show binding activity in vitro will be subjected to in vivo testing using the Watanabe Heritable Hyperlipidemic rabbit and the LDL receptor knockout mouse, two animal models of human FH.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Biotechnology Resource Grants (P41)
Project #
5P41RR002305-13
Application #
5224046
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
13
Fiscal Year
1996
Total Cost
Indirect Cost
Pang, Henry; Bow, Cora; Cheung, Jason Pui Yin et al. (2018) The UTE Disc Sign on MRI: A Novel Imaging Biomarker Associated With Degenerative Spine Changes, Low Back Pain, and Disability. Spine (Phila Pa 1976) 43:503-511
Ferraro, Pilar M; Jester, Charles; Olm, Christopher A et al. (2018) Perfusion alterations converge with patterns of pathological spread in transactive response DNA-binding protein 43 proteinopathies. Neurobiol Aging 68:85-92
Ercan, Altan; Kohrt, Wendy M; Cui, Jing et al. (2017) Estrogens regulate glycosylation of IgG in women and men. JCI Insight 2:e89703
Xie, Long; Dolui, Sudipto; Das, Sandhitsu R et al. (2016) A brain stress test: Cerebral perfusion during memory encoding in mild cognitive impairment. Neuroimage Clin 11:388-397
Yadav, Santosh K; Kathiresan, Nagarajan; Mohan, Suyash et al. (2016) Gender-based analysis of cortical thickness and structural connectivity in Parkinson's disease. J Neurol 263:2308-2318
Finkelstein, Joel S; Lee, Hang; Leder, Benjamin Z et al. (2016) Gonadal steroid-dependent effects on bone turnover and bone mineral density in men. J Clin Invest 126:1114-25
Rosenbaum, Michael; Leibel, Rudolph L (2016) Models of energy homeostasis in response to maintenance of reduced body weight. Obesity (Silver Spring) 24:1620-9
Machida, Manabu; Panasyuk, George Y; Wang, Zheng-Min et al. (2016) Radiative transport and optical tomography with large datasets. J Opt Soc Am A Opt Image Sci Vis 33:551-8
Ban, H Y; Schweiger, M; Kavuri, V C et al. (2016) Heterodyne frequency-domain multispectral diffuse optical tomography of breast cancer in the parallel-plane transmission geometry. Med Phys 43:4383
Haris, Mohammad; Yadav, Santosh K; Rizwan, Arshi et al. (2015) T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease. Neuroimage Clin 7:598-604

Showing the most recent 10 out of 414 publications